Novo Nordisk Aktie
WKN: 866931 / ISIN: US6701002056
|
18.12.2025 09:50:00
|
Better Pharmaceutical Buy: Eli Lilly vs. Novo Nordisk
Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are two of the leading companies in the fast-growing GLP-1 weight loss market. These healthcare companies have tremendous long-term growth prospects due to their promising GLP-1 products.Lately, however, they've been going in opposite directions. Shares of Eli Lilly are up 35% over the past 12 months, while Novo Nordisk is down 53% (returns are as of Dec. 15). But will those trends hold up over the long haul? Here's a closer look at which healthcare stock may be the better buy right now.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Novo Nordisk (spons. ADRs)mehr Nachrichten
Analysen zu Novo Nordisk (spons. ADRs)mehr Analysen
Aktien in diesem Artikel
| Novo Nordisk (spons. ADRs) | 40,40 | -1,94% |
|